Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection

被引:81
作者
Biswas, PS
Banerjee, K
Kinchington, PR
Rouse, BT
机构
[1] Univ Tennessee, Dept Microbiol, Coll Vet Med, Knoxville, TN 37996 USA
[2] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA
关键词
HSV-1; cornea; IL-6; angiogenesis; VEGF;
D O I
10.1016/j.exer.2005.05.001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Following ocular HSV-1 infection, neovascularisation of the avascular cornea is a critical event in the pathogenesis of herpetic stromal keratitis. This present study evaluates the role of proinflammatory cytokines such as IL-6 in corneal angiogenesis following virus infection. Both in vivo and in vitro data indicate that IL-6 produced from virus-infected cells can stimulate noninfected resident corneal cells and other inflammatory cells in a paracrine manner to secrete VEGF, a potent angiogenic factor. Antibody neutralisation of IL-6 resulted in a significant decrease in the number of VEGF producing cells in the cornea. Thus, our results further demonstrate the close relationship between proinflammatory cytokines and VEGF-induced corneal neovascularisation. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:46 / 54
页数:9
相关论文
共 26 条
[1]   Viral replication is required for induction of ocular immunopathology by herpes simplex virus [J].
Babu, JS ;
Thomas, J ;
Kanangat, S ;
Morrison, LA ;
Knipe, DM ;
Rouse, BT .
JOURNAL OF VIROLOGY, 1996, 70 (01) :101-107
[2]   CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis:: A role for IL-6-induced neovascularization [J].
Banerjee, K ;
Biswas, PS ;
Kim, B ;
Lee, S ;
Rouse, BT .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :1237-1245
[3]   Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein [J].
Biswas, PS ;
Banerjee, K ;
Zheng, M ;
Rouse, BT .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 76 (04) :868-875
[4]   Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: Possible role for IL-1 in herpetic stromal keratitis pathogenesis [J].
Biswas, PS ;
Banerjee, K ;
Kim, B ;
Rouse, BT .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3736-3744
[5]   Bystander activation involving T lymphocytes in herpetic stromal keratitis [J].
Deshpande, S ;
Zheng, M ;
Lee, S ;
Banerjee, K ;
Gangappa, S ;
Kumaraguru, U ;
Rouse, BT .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2902-2910
[6]  
Deshpande Shilpa, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007604
[7]  
Fenton RR, 2002, INVEST OPHTH VIS SCI, V43, P737
[8]   A COMPARISON OF CORNEAL, PANCREAS, AND SKIN CRAFTS IN MICE - A STUDY OF THE DETERMINANTS OF TISSUE IMMUNOGENICITY [J].
GUYMER, RH ;
MANDEL, TE .
TRANSPLANTATION, 1994, 57 (08) :1251-1262
[9]   HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: Selective upregulation [J].
Kanangat, S ;
Babu, JS ;
Knipe, DM ;
Rouse, BT .
VIROLOGY, 1996, 219 (01) :295-300
[10]   Chemokines and ocular pathology caused by corneal infection with herpes simplex virus [J].
Kumaraguru, U ;
Davis, I ;
Rouse, BT .
JOURNAL OF NEUROVIROLOGY, 1999, 5 (01) :42-47